Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys)

被引：2

作者：

Cha, Yun-Ji ^{[1
]}

Jeon, Sae-Bom ^{[1
]}

Oh, Jaewon ^{[3
]}

Lee, Seung-Tae ^{[4
]}

Kim, Sangwoo ^{[8
,9
]}

Kim, Hyoeun ^{[1
]}

Choi, Jungyoon ^{[1
]}

Choi, Hyo-Kyoung ^{[5
]}

Won, Dongju ^{[4
]}

Choi, Jong Rak ^{[4
]}

Kim, Seok-Jun ^{[6
,7
]}

Park, Sahng Wook ^{[1
,2
]}

Kang, Seok-Min ^{[3
]}

Lee, Seung-Hyun ^{[1
,2
]}

机构：

[1] Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea

[2] Yonsei Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, Coll Med,Brain Korea 21 Project, 50-1 Yonsei Ro, Seoul 03722, South Korea

[3] Yonsei Univ, Severance Cardiovasc Hosp, Cardiovasc Res Inst, Div Cardiol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea

[4] Yonsei Univ, Dept Lab Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea

[5] Korea Food Res Inst, Res Grp Healthcare, Wanju Gun 55365, Jeollabuk Do, South Korea

[6] Chosun Univ, Dept Biomed Sci, Dept Integrat Biol Sci, Gwangju 61452, South Korea

[7] Chosun Univ, BK21 FOUR Educ Res Grp Age Associated Disorder Co, Gwangju 61452, South Korea

[8] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, 50-1 Yonsei Ro, Seoul 03722, South Korea

[9] Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea

来源：

STEM CELL RESEARCH | 2022年 / 60卷

基金：

新加坡国家研究基金会;

关键词：

ALPHA-TROPOMYOSIN MUTATION;

D O I：

10.1016/j.scr.2022.102707

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Dilated cardiomyopathy (DCM) is one of the leading causes of heart transplantation. The clinical feature of DCM is characterized by enlarged heart and impaired function of the left or both ventricles, while its etiology is varied. In this study, we generated YCMi005-A, a human-induced pluripotent stem cell (hiPSC) line from a patient with DCM carrying the missense mutation of p.Glu192Lys in the TPM1 genes. YCMi005-A, an established hiPSC, showed the normal karyotype (46, XX) and high expression of pluripotency markers. In addition, it was confirmed that YCMi005-A has the differentiation potential assessed by staining of three germ layer markers.

引用

页数：5

共 50 条

[1] Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p. Glu161Lys mutation
Cattelan, Giada
Frommelt, Laura Sophie
Volani, Chiara
Colliva, Andrea
Ciucci, Giulio
Paldino, Alessia
Dal Ferro, Matteo
Di Segni, Marina
Silipigni, Rosamaria
Pramstaller, Peter P.
De Bortoli, Marzia
Zacchigna, Serena
Rossini, Alessandra
STEM CELL RESEARCH, 2023, 71
[2] Establishment of a human induced pluripotent stem cell line from a patient with dilated cardiomyopathy
Ye, Lingqun
Ni, Baoqiang
Wu, Hongchun
Han, Xinglong
Li, Huadong
Liu, Junwei
Hu, Shijun
Lei, Wei
STEM CELL RESEARCH, 2024, 78
[3] Generation of an Induced Pluripotent Stem Cell Line ICGi045-A of a RASopathy Patient Carrying p.Glu329Lys Variant in SOS1
Dementyeva, E. V.
Zaytseva, A. K.
Minina, J. M.
Melnik, O. V.
Zakian, S. M.
Kostareva, A. A.
RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2024, 55 (01) : 26 - 33
[4] Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation
Shimoda, Yuzuno
Murakoshi, Nobuyuki
Mori, Haruka
Xu, DongZhu
Tajiri, Kazuko
Hemmi, Yasuko
Sato, Iori
Noguchi, Michiya
Nakamura, Yukio
Hayashi, Yohei
Ieda, Masaki
STEM CELL RESEARCH, 2022, 62
[5] A human induced pluripotent stem cell line, NIMHi016-A, established from fibroblasts of a neuromuscular disease patient carrying PGK1/p. Asn5Lys variant
Nandeesh, Bevinahalli Nanjegowda
Maheshwari, Baduvandra Chettiyappa
Nimonkar, Madhura Milind
Deepha, Sekar
Govindaraj, Periyasamy
Mehta, Bhupesh
Markandeya, Yogananda S.
STEM CELL RESEARCH, 2025, 83
[6] Generation of a human induced pluripotent stem cell line YCMi004-A from a patient with dilated cardiomyopathy carrying a protein-truncating mutation of the Titin gene and its differentiation towards cardiomyocytes
Lee, Sun-Ho
Oh, Jaewon
Lee, Seung-Tae
Won, Dongju
Kim, Sangwoo
Choi, Hyo-Kyoung
Kim, Seok-Jun
Han, Hyunho
Yoon, Minjae
Choi, Jong Rak
Yoon, Ho-Geun
Park, Sahng Wook
Kang, Seok-Min
Lee, Seung-Hyun
STEM CELL RESEARCH, 2022, 59
[7] Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene
Jeon, Sae-Bom
Kim, Hyoeun
Chun, Kyeong-Hyeon
Oh, Jaewon
Kwon, Chulan
Choi, Hyo-Kyoung
Kim, Sangwoo
Kim, Hyoung-Pyo
Kim, In-Cheol
Yoo, Jung-Yoon
Park, Sahng Wook
Kang, Seok-Min
Lee, Seung-Hyun
STEM CELL RESEARCH, 2023, 67
[8] Establishment of a novel human iPSC line (YCMi003-A) from a patient with dilated cardiomyopathy carrying genetic variant LMNA p.Asp364His
Oh, Jaewon
Lee, Sun-Ho
Choi, Jungyoon
Choi, Jong Rak
Kim, Sangwoo
Cha, Yun-Ji
Choi, Hyo-Kyoung
Won, Dongju
Yoon, Ho-Geun
Park, Sahng Wook
Kang, Seok-Min
Lee, Seung-Tae
Lee, Seung-Hyun
STEM CELL RESEARCH, 2021, 56
[9] An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene
Huang, Wei
Xu, Miao
Li, Rong
Baskfield, Amanda
Kouznetsova, Jennifer
Beers, Jeanette
Zou, Jizhong
Liu, Chengyu
Zheng, Wei
STEM CELL RESEARCH, 2019, 37
[10] Human induced pluripotent stem cell line (FDHSi005-A) derived from a patient with a deep intronic variant in the GNE gene
Jiao, Kexin
Zhang, Jialong
Wang, Ningning
Gu, Xingyu
Chang, Xuechun
Xia, Xingyu
Zhu, Bochen
Gao, Mingshi
Cheng, Nachuan
Zhao, Chongbo
Xi, Jianying
Zhu, Wenhua
STEM CELL RESEARCH, 2024, 81

← 1 2 3 4 5 →